Background--There has been a paradigm shift in the definition of timing of early invasive strategy (EIS) for patients admitted with non-ST-elevation myocardial infarction (NSTEMI) in the last decade. Data on trends of EIS for NSTEMI and associated in-hospital outcomes are limited. Our aim is to analyze temporal trends in the incidence, utilization of early invasive strategy, and in-hospital outcomes of NSTEMI in the United States.
A cute coronary syndromes (ACS) continue to be a major cause of morbidity and mortality. 1 Data from the United States and Europe have reported a decrease in the incidence of ST-elevation myocardial infarction (STEMI) with an increase in non-ST-elevation myocardial infarction (NSTEMI) in the past decade. [2] [3] [4] [5] [6] Current 2012 American College of Cardiology/ American Heart Association (ACC/AHA) guidelines recommend early invasive strategy (EIS) for management of patients with NSTEMI and refractory angina or electrical or hemodynamic insufficiency (class IB), initially stabilized patients with NSTEMI, and high risk of clinical events (class IA). The early invasive approach (within 12 to 24 hours of presentation) to reduce ischemic complications is also recommended in initially stabilized high-risk patients with NSTEMI (class IIA).
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The optimal timing of EIS has been debated and undergone a paradigm shift in the last decade. The transition from 48 hours to within 24 hours occurred after the publication of the Timing of Intervention in Acute Coronary Syndromes (TIMACS) trial in 2009. 8, 9 However, there is a paucity of information with regard to the secular trends in utilization of EIS in patients with NSTEMI and how this may vary among different NSTEMI patient populations. Using a large nationwide administrative database, the present study aimed to analyze and describe age-, sex-, and race/ethnicity-specific trends in the incidence, utilization of EIS, and in-hospital outcomes for NSTEMI in the United States from 2002 to 2011.
Methods Data Source
Data were obtained from the 2002 to 2011 Nationwide Inpatient Sample (NIS) databases. The NIS, sponsored by the Agency for Healthcare Research and Quality as a part of the Healthcare Cost and Utilization Project (HCUP), is the largest publicly available all-payer inpatient care database in the United States. It contains discharge-level data from %8 million hospital stays from approximately 1000 hospitals designed to approximate a 20% stratified sample of all community hospitals in the United States. Criteria used for stratified sampling of hospitals include hospital ownership, bed size, teaching status, urban or rural location, and geographic region. Discharge weights are provided for each patient discharge record, which were used to obtain national estimates. Discharge weights are calculated for NIS data by first stratifying the NIS hospitals on the same variables used for creating the sample. A weight is then calculated for each stratum by dividing the number of universe discharges in that stratum (obtained from American Hospital Association data) by the number of NIS discharges in the stratum. Weighted estimates are calculated by uniformly applying stratum weights to the discharges according to the stratum from which the discharge was drawn. Weights are assigned to each discharge and are stored in each record in the data element, DISCWT. When the discharge weights are applied to the unweighted NIS data, the result is an estimate of the number of discharges for all inpatient discharges from community hospitals in the United States. This study was deemed exempt by the New York Medical College Institutional Review Board (Valhalla, NY) because HCUP-NIS is a public database with no personal identifying information.
Study Population
We used the International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM), codes 410.xx to identify all patients ≥40 years of age with the principal diagnosis of acute myocardial infarction (AMI; N=6 512 372).
Patients with the principal diagnosis of NSTEMI were then identified using ICD-9-CM codes 410.7x (n=3 981 119). We chose the principal diagnosis because it is considered the primary reason for hospital admission. EIS was defined as coronary angiography (ICD-9-CM procedure codes 88.55, 88.66, 37.22, or 37.23) with or without revascularization (ie, percutaneous coronary intervention (PCI; ICD-9-CM procedure codes 00.66, 36.01, 36.02, 36.05, 36.06 and 36.07) or coronary artery bypass graft surgery (CABG; ICD-9-CM procedure code 36.1x) on day 0 (considered within 24 hours of admission) or on days 0 or 1 (considered within 48 hours of admission).
Outcomes Measured
We initially studied the overall age-, sex-, and race/ethnicityspecific trends in the incidence of NSTEMI. We then examined the trends in utilization of the EIS in patients with NSTEMI. Our primary outcome of interest was all-cause, in-hospital mortality, defined as death during the hospitalization encounter in the NIS database. We used the average length of stay and total hospital cost as secondary outcomes. We analyzed the overall age-, sex-, and race/ethnicity-specific trends in utilization of the EIS, risk-adjusted in-hospital mortality, average length of stay, and total hospital cost in patients with NSTEMI. The NIS provides total charges, which reflect the amount a hospital billed for services, rather than actual costs or the amount a hospital received in payment. In this study, we used the HCUP Cost-to-Charge Ratio File developed by the Agency for Healthcare Research and Quality (AHRQ) to translate total charges into costs. Each file contains hospitalspecific cost-to-charge ratios based on all-payer inpatient cost for nearly every hospital in the NIS databases. Cost information 
Statistical Analysis
Weighted data were used for all statistical analyses. For trend analysis, we used Mantel-Haenszel's chi-square (v 2 ) test of linear association for categorical variables and linear regression for continuous variables. To assess whether the incidence of NSTEMI, utilization of EIS, or in-hospital mortality has changed over time, unadjusted and multivariable adjusted logistic regression models were constructed. Our independent variable, calendar year, was initially entered as a continuous variable in the regression models to obtain unadjusted and adjusted odds ratios (ORs; per year) for the temporal trends. To determine whether there was a temporal variability from year to year in the incidence of NSTEMI, utilization of EIS, or in-hospital mortality, we also evaluated calendar year as a categorical variable, with 2002 as the reference year. The regression models adjusted for all demographics (except sex and race/ethnicity for sex and race/ethnicity-specific trends, respectively), hospital characteristics, and all Elixhauser and other clinically relevant comorbidities. The methodology has been utilized in our previous analysis of NIS databases. 10, 11 We graphically displayed the unadjusted and adjusted ORs and 95% confidence intervals (CIs) for incidence of NSTEMI, utilization of EIS for NSTEMI, or in-hospital mortality over time.
Statistical analysis was performed using IBM SPSS Statistics 20.0 (IBM Corp., Armonk, NY). All P values were 2 sided with a significance threshold of P<0.001 (a lowerthan-usual P-value threshold was selected to correct for the effects of a large sample size as well as inflation of type I error because of repeated testing using a large number of variables). Categorical variables are expressed as percentage and continuous variables as meanAE SEM. OR, and 95% CI were used to report the results of logistic regression. Figure 1 ; Table 2 Increase in NSTEMI proportions were also observed across all races. AfricanAmerican patients showed the greatest proportional increase ( Figure 2 ; Table 2 ). Table 3 depicts the baseline demographic, hospital, and clinical characteristics of patients admitted with NSTEMI from 2002 to 2011. There was a slight decrease in mean age at admission during the study period (70.36AE13.11 years in 2002 versus 69.87AE13.53 in 2011; P<0.001). More specifically, there was an increase in the proportion of NSTEMI patients aged 40 to 64 years and decrease in those aged ≥75 years from 2002 to 2011 (P trend <0.001). Similarly, there was a small, but statistically significant, increase in the proportion of men (56% in 2002 to 57.5% in 2011; P trend <0.001) and a consequent decrease in the proportion of women (44.0% in 2002 to 42.5% in 2011; P trend <0.001) with NSTEMI during the study period. The prevalence of smoking, dyslipidemia, CAD, previous MI, carotid artery disease, diabetes mellitus, hypertension, obesity, peripheral vascular disease, chronic renal failure, alcohol abuse, deficiency anemias, coagulopathy, fluid/electrolyte disorders, and previous PCI increased from 2002 to 2011 (P trend <0.001 for all). The prevalence of heart failure and chronic pulmonary diseases remained relatively constant throughout the study period. Table 4 ).
Results

Temporal Trends in NSTEMI
Changing Baseline Characteristics of Patients With NSTEMI
Trends in EIS
We also analyzed the utilization of EIS at day 0 or 1. Results showed a temporal increase in the overall as well as the age-, race/ethnicity-, and sex-stratified cohorts (Figures 3 and 4; Table 5 ). Figure 2 . Age, sex, and race/ethnicity specific trends in incidence rates of non-ST-elevation myocardial infarction. A, Age stratified; P trend <0.001, (B) sex stratified; P trend <0.001, and (C) race/ethnicity stratified; P trend <0.001. AMI indicates acute myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction. Figure 6 ; Table 6 ).
Secondary Outcomes: Cost and Length of Stay
For secondary outcome analysis, we studied the temporal trends in cost and length of stay. Detailed results of the length and cost of stay temporal trends stratified by age, sex, and race/ethnicity are shown in Tables 7 and 8 Figure 4 . Age, sex, and race/ethnicity specific trends in utilization of early invasive strategy (EIS) for non-ST-elevation myocardial infarction. A, Age stratified, EIS day 0; P trend <0.001, (B) sex stratified, EIS day 0; P trend <0.001, (C) race/ethnicity stratified, EIS day 0; P trend <0.001, (D) age stratified, EIS day 0 or 1; P trend <0.001, (E) sex stratified, EIS day 0 or 1; P trend <0.001, and (F) race/ethnicity stratified, EIS day 0 or 1; P trend <0.001. NSTEMI indicates non-ST-elevation myocardial infarction. Table 4 . Multivariable adjustment for baseline demographics, hospital characteristics, and 29 Elixhauser and other clinically relevant comorbidities as outlined in the methodology. Adjusted odds ratios (OR; per year) for trend were determined using logistic regression models evaluating calendar year as a continuous variable. Numbers in parenthesis represent 95% confidence interval.
Discussion
We report an increasing trend in the proportion of NSTEMI admissions for the overall cohort and in the age-, sex-, and race/ethnicity-stratified subgroups from 2002 to 2011. This is associated with an increase in utilization of EIS, decreased in-hospital mortality, and decreased length of stay during the same period. Analysis of the National Registry of Myocardial Infarction from 1990 to 2006 reported an increase in the proportion of NSTEMI from 14.2% in 1990 to 59.1% in 2006 (P<0.001). 2 The proportional increase in NSTEMI may be the result of an aging population, increasing chronic comorbidities, and reduction in smoking. Part of the increase in the proportion of NSTEMI in our study may be attributable to increased utilization and higher sensitivity of cardiac biomarkers (troponins). In the age-and sex-stratified analysis, patients ≥75 years and women had the greatest proportional increase in NSTEMI. Women are also more likely to present with NSTEMI, compared to men. 12 Older patients are more likely to be women and have significant comorbidities that predispose them to NSTEMI. On trend analysis of baseline characteristics, we report an increase in the proportion of patients in the 40 to 64 years of age group. This is in concordance with the analysis of Get With The Guidelines Coronary Artery Disease Registry from 2003 to 2008, 13 with that age group representing the fastestgrowing segment of our population over the years. Importantly, there was a temporal increase in utilization of the EIS in the NSTEMI patient population. Meta-analysis of randomized, control trials has consistently shown a benefit of EIS in the setting of NSTEMI, especially in the high-risk patient population. 48 hours) was not utilized in a majority of high-risk patients with NSTEMI. 18 They reported male sex, ischemic electrocardiographic changes, younger age, positive biomarkers, lack of congestive heart failure, lack of renal insufficiency, and white race as predictors of early invasive management. We analyzed the trends in both day 0 and day 0 or 1 of presentation. Utilization of EIS at day 0 increased from 14.9% in 2002 to 21.8% in 2011 (P<0.001), and utilization of EIS at day 0 or 1 increased from 27.8% in 2002 to 41.4% in 2011 (P<0.001). The increase in utilization was consistent among all age-, race/ethnicity-, and sex-stratified subgroups after multivariable adjustment. Men had a higher proportional increase in EIS at both day 0 and day 0 or 1 of presentation. Previous studies have discussed the sex differences in the invasive management of ACS, with women being managed less aggressively than men. Interestingly, patients ≥75 years of age had a higher proportional increase in EIS at day 0 and patients 40 to 64 years of age had an overall higher proportional increase at day 0 or 1. Chin et al., 21 using the linked CRUSADE registry and Medicare and Medicaid claims data, reported an increased utilization of evidence based NSTEMI care and decline in in-hospital mortality in 2006, compared with 2003 (OR, 0.82; 95% CI, 0.67 to 1.00; P=0.045) in patients ≥65 years of age with NSTEMI. Recent trend analysis from Denmark also reported an increase in initiation of coronary angiography for first-time NSTEMI admissions at 3 days from 18.2% in 2001 to 55.7% to 2009. 22 We also report a decrease in risk-adjusted in-hospital mortality and length of stay for patients admitted with NSTEMI. The decline in in-hospital mortality was observed in patients receiving EIS as well as those not receiving EIS. This observation is consistent with improvement in, or better adherence to, medical therapy, independent of EIS utilization. The lower in-hospital mortality observed in the EIS-managed patients is likely the result of patient selection bias, as previously demonstrated by analysis of the CRUSADE registry, 18 and no causal association between EIS and in-hospital mortality can be inferred from the results of our study. The decline in overall in-hospital mortality was most prominent in those ≥75 years of age. We have previously reported a 24% relative reduction of in-hospital mortality in octogenarians treated with the early invasive approach versus the initial conservative strategy (OR, 0.76; 95% CI, 0.74 to 0.78; P<0.001).
23 However, it is not possible to conclusively establish a causal relationship between increasing utilization of EIS and decreasing in-hospital mortality from this study.
Limitations
This study has certain limitations. Because this is a retrospective, observational study, the possibility of selection bias and residual measured and unmeasured confounding cannot be completely eliminated. NIS is an administrative database; there is the potential for unrecognized miscoding of diagnostic and procedure codes. There is a possibility that widespread troponin utilization in the last decade may have contributed to the increase in NSTEMI diagnosis and also potentially decreased case severity of those classified as NSTEMI. Also, conditions other than ACS may have led to troponin elevations and hence miscoding of NSTEMI exists. Clinical presentation and medication utilization variables are not available in this administrative database. It is our assumption that day 0 corresponds to ≤24 hours and days 0 or 1 corresponds to ≤48 hours, because the database does not provide the timing of procedure in hours. For trends in Table 8 . total hospital costs, we did not convert hospital costs into inflation-adjusted constant dollars. The NIS databases do not include NSTEMI hospitalizations for veterans hospitalized in Veterans Affairs hospitals. We could also not account for patients transferred in from other hospitals. Last, outcomes in the NIS database are limited to in-hospital events and causes of death are not differentiated. However, these potential limitations may be partially compensated by the large size of the database and the ability to obtain nationwide estimates using the discharge weights provided.
Conclusions
In this large, nationwide analysis of patients with MI, we report an increase in proportion of NSTEMI with increasing utilization of EIS in the United States. We also report a decrease in in-hospital mortality and decrease in length of stay during the study period. The improved outcomes may reflect greater adherence to the evolving guideline-recommended therapies. Nevertheless, age-, sex-, and race/ethnicity-specific differences in the management and outcomes of NSTEMI were observed, and further studies are needed to develop strategies to ensure more equitable care for NSTEMI. and (E) timing of invasive strategy (P trend <0.001 for all).
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